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Increasing evidence suggests that P2 receptors (P2Rs)
in airway epithelial cells perform critical functions in
auto- or paracrine regulation of fluid and mucus secre-
tion. In the present study, we characterized the effects
of P2R stimulation on Na-K-2Cl cotransporter
(NKCC) activity in normal human nasal epithelial
(NHNE) cells. [Ca2]i and pHi were measured in primary
cultures of NHNE cells using a double perfusion cham-
ber, which enabled us to analyze membrane-specific
transporter activities. NKCC activities were estimated
by the pHi reduction due to Na
-dependent and bumet-
anide-sensitive intracellular uptake of NH4
. NKCC ac-
tivities were observed in the basolateral membrane, but
not in the luminal membrane, of NHNE cells. Interest-
ingly, P2Rs were expressed in both membranes, and the
stimulation of either luminal or basolateral P2R in-
creased NKCC activity. Blockades of luminal Cl chan-
nels, basolateral K channels, or protein kinase C did
not affect the activation of NKCC by basolateral P2R
stimulation. The effects of luminal P2R stimulation were
partially reduced by Cl channel blockers. However,
chelation of intracellular Ca2 by 1,2-bis(2-aminophe-
noxy)ethane-N,N,N,N-tetraacetic acid (BAPTA) treat-
ment completely blocked the stimulatory effects of lu-
minal and basolateral P2Rs on NKCC. In addition,
increasing [Ca2]i by treatment with ionomycin-stimu-
lated NKCC activity. These results provide evidence
that stimulation of P2Rs directly activates basolateral
NKCC by Ca2-dependent pathways in NHNE cells,
which is an important aspect of the purinergic regula-
tion of ion and fluid secretions in human airway epithe-
lia under physiologic and pathologic conditions.
The mucosal surfaces of the airway tract are covered with
airway surface fluid (ASF),1 which performs critical roles in the
proper functioning of airway tracts and in protecting the lining
epithelia (1–3). The hypersecretion or the contraction of ASF is
associated with a wide spectrum of respiratory tract diseases
from allergic rhinitis to cystic fibrosis (CF). Chronic volume
contraction, either by defects in secretion or by dysregulated
hyper-absorption, induces the formation of hyper-viscous mu-
cus, which is thought to be the underlying pathogenic mecha-
nism of CF (1–2). On the other hand, in stimulated conditions
such as in allergic inflammation, airway epithelia actively se-
crete ion and fluids by locally induced neurotransmitters and
inflammatory mediators (4).
It is generally accepted that transepithelial Cl transport is
the major driving force for fluid secretions in airway epithelia
(5, 6). During the past decades, extensive investigations have
been performed on the molecular nature and the regulatory
mechanisms accounting for this important biologic process.
However, most of the studies have focused on the luminal Cl
exit pathways, especially on the transporter named cystic fi-
brosis transmembrane conductance regulator (CFTR), in which
gene mutations cause CF and other related disorders (7, 8).
Equally important are the basolateral Cl uptake pathways. In
fact, recent evidence suggests that the activities of basolateral
Na-K-2Cl cotransporter (NKCC) are the rate-limiting step
of ion and fluid secretions in Cl-secreting epithelia (6, 9). In
addition to NKCC, several other mechanisms can mediate in-
tracellular Cl uptake: 1) the parallel activation of Na/H and
Cl/HCO3
 exchangers; 2) other members of cation-chloride
cotransporters such as K-Cl cotransporter (KCC) and Na-
Cl cotransporter (NCC); and 3) a Cl-ATPase pump. How-
ever, these transporters are expressed in specific tissues or are
active in specific conditions, whereas NKCC is known to be
ubiquitously expressed and responsible for most of the intra-
cellular Cl uptake in secretory epithelia (5). To date, two
isoforms of NKCC have been identified, NKCC1 and NKCC2.
Both belong to the cation-chloride cotransporter family, which
has 12 membrane-spanning domains (5, 10). Among them,
NKCC1 is in general expressed in the basolateral membrane of
Cl-secreting epithelia (5, 6).
As in other CFTR- and NKCC1-expressing epithelial tissues,
cells in the airway tract are under control of several agonists,
which include agonists in the cholinergic and adrenergic sys-
tems. Recently, the purinergic system, a different type of reg-
ulating system, has attracted increasing attention in the reg-
ulation of transepithelial transport due to its unique properties
(3). For example, purinergic receptors (P2Rs) are expressed in
the luminal membrane as well as in the basolateral membrane
of many epithelial cells (11, 12). In addition, accumulating
evidence suggests that activation of P2Rs is not only involved
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in the regulation of physiologic function but also associated
with pathologic conditions (3). Therefore, a dissection of the
effects of P2R on the basolateral Cl uptake pathways would
improve our understanding of physiological and pathological
regulation of airway secretions.
We employed primary cultures of normal human nasal epi-
thelial (NHNE) cells as a model of human airway epithelia.
Alterations in nasal secretion are frequently associated with
common medical problems such as allergic rhinitis or the com-
mon cold (4). In addition, cells in the nasal mucosa share some
common features with cells in other airway epithelia in both
the morphological and molecular aspects. For example, nasal
epithelia have cilia on the luminal surface and co-express
CFTR and epithelial Na channel (ENaC) on the luminal mem-
brane, similar to cells in the middle or lower airway tract (13).
Therefore, an investigation of the nasal secretory mechanism
itself has significant clinical meanings, and further, the results
may be extrapolated to the secretory mechanisms of cells in the
middle and lower airway tracts.
In the present study, we analyzed the effects of P2R activa-
tion on NKCC in human nasal epithelia. NKCC activities were
observed only in the basolateral membrane of NHNE cells, and
immunoblotting using specific antibodies revealed the expres-
sion of NKCC1. Interestingly, P2Rs were expressed in both
luminal and basolateral membranes, and the stimulation of
either luminal or basolateral P2R increased the basolateral
NKCC activity. Finally, the stimulatory effects of P2R on
NKCC were completely dependent on intracellular Ca2 sig-
nals. These findings will provide the basis for understanding
the purinergic control of secretions in human nasal and airway
epithelia under physiologic and pathologic conditions.
MATERIALS AND METHODS
Chemicals and Solutions—The fluorescent probes, Fura-2-AM and
2,7-bis(2-carboxyethyl)-5 (6)-carboxyfluorescein acetoxymethyl ester
(BCECF-AM), and the intracellular Ca2 chelator 1,2-bis(2-aminophe-
noxy)ethane-N,N,N,N-tetraacetic acid acetoxymethyl ester (BAPTA-
AM) were purchased from Molecular Probes (Eugene, OR). The Cl
channel blocker 5-nitro-2-(3phenylpropyl-amino)benzoic acid (NPPB)
was obtained from Alexis (Carlsbad, CA), and 4,4-diisothiocyanatostil-
bene-2,2-disulfonic acid disodium salt (DIDS) was from Calbiochem.
Ammonium gluconate was purchased from Pfaltz & Bauer (Waterbury,
CT). All other chemicals including ATP, ouabain, bumetanide, BaCl2,
Go6976, and rottlerin were purchased from Sigma.
The standard HEPES-buffered perfusate was termed solution A and
contained (in mM) 140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 D-glucose, and
10 HEPES (pH 7.4 with NaOH). The Na-free solution B was prepared
by replacing Na with N-methyl-D-glucamine in solution A (pH 7.4
with Tris). The Cl-free solution C contained (in mM) 140 Na-gluco-
nate, 5 K-gluconate, 1 MgSO4, 9.3 hemicalcium cyclamate, 10 D-glu-
cose, and 10 HEPES (pH 7.4 with NaOH). In the measurements of NH4

uptake, 20 mM Na or N-methyl-D-glucamine was replaced with
equimolar NH4
 using NH4Cl or NH4
-gluconate in each solution. The
osmolarity of all solutions was adjusted to 310 mosM with the major salt
prior to use.
Culture of NHNE Cells—Primary cultures of NHNE cells were pre-
pared as described previously (14, 15). All procedures were approved by
the Institutional Review Board of Yonsei Medical Center. Passage-2
NHNE cells were plated on a collagen-coated semipermeable membrane
with a 0.45-m pore size (Transwell-clear; Costar Co., Cambridge, MA)
at a density of 1.0  104 cells/cm2 for intracellular pH (pHi) and [Ca
2]i
measurements. The cells were maintained in 1:1 mixture of bronchial
epithelial growth medium and Dulbecco’s modified Eagle’s medium
containing 10% fetal bovine serum and all supplements (14). Mem-
branes bearing cultured cells (culture area, 0.3 cm2) were floated on the
culture medium in Petri dishes and incubated for 4–5 days until the
cells formed a functionally polarized monolayer.
Measurement of [Ca2]i—[Ca
2]i levels in the monolayers were de-
termined using protocols reported previously with slight modification
(16). Briefly, after achieving confluency, the cells were loaded with
Fura-2 by incubating in a medium containing 3 M Fura-2-AM and 1.6
M pluronic F127 (for 30 min at 37 °C). A membrane bearing Fura-2-
loaded cells was mounted in a miniature Ussing chamber (AKI Insti-
tute, University of Copenhagen, Copenhagen, Denmark) attached to the
stage of an inverted microscope. The membrane was located between
the two half-chambers, which separated the chamber into a luminal
(upper) and a basolateral (lower) compartment. A transparent coverslip
was placed at the bottom of the perfusion chamber, which allowed
fluorescence measurements from the dye-loaded monolayers using ob-
jective lenses having a long working distance (more than 2 mm). Sep-
arate luminal and basolateral perfusates were delivered to the chamber
after warming (37 °C). Fura-2 fluorescence was recorded (Delta Ram;
PTI Inc., South Brunswick, NJ) at excitation wavelengths of 350 and
380 nm, and the 350/380 fluorescence ratio was calibrated by exposing
the cells to solutions containing high and low concentrations of Ca2
and 10 M ionomycin.
Measurements of Intracellular pH (pHi) and NKCC Activity—pHi
was measured in the monolayers using the pH-sensitive fluorescent
probe BCECF. Cells were loaded with BCECF for 10 min at room
temperature in solution A containing 2.5 M BCECF-AM and mounted
in the miniature Ussing chamber described for [Ca2]i measurements.
BCECF fluorescence was recorded and calibrated using a previously
described protocol (16). Briefly, the fluorescence at excitation wave-
lengths of 490 and 440 nm was recorded using a recording setup (Delta
Ram; PTI Inc.), and the 490/440 ratios were calibrated intracellularly
by perfusing the cells with solutions containing 145 mM KCl, 10 mM
HEPES, and 5 M nigericin with the pH adjusted to 6.2–7.6.
Na-K-2Cl cotransporter activity was estimated from the pHi
decrease caused by the intracellular uptake of NH4
 using the methods
of Evans and Turner (17) with modification. As shown in Fig. 1, when
challenged with 20 mM NH4Cl solutions, cells were rapidly alkalinized
(0–2 s) due to the intracellular diffusion of NH3. Then, if the cells have
NH4
-transporting machineries, the pHi of the cells would be decreased
due to the intracellular uptake of NH4
. As detailed under “Results,”
most of the intracellular NH4
 uptake measured in ouabain (100 M)-
and Na (140 mM)-containing perfusates was a function of NKCC in
NHNE cells. Typically, the first 10–40 s of the initial linear portion of
the pHi decreases due to Na
-dependent and ouabain-insensitive intra-
cellular NH4
 uptake (shorter times were used for more rapid decreases)
was fitted to a linear equation using the Felix software (version 1.4;
PTI Inc.).
Buffer capacity of NHNE cells was calculated by measuring pHi in
response to 5–40 mM NH4Cl pulses in Na
-free solutions (18), which
applied to both luminal and basolateral sides simultaneously. In each
experiment, the intrinsic buffer capacity (i) showed a negative linear
relationship with pHi between 6.4 and 7.6. The i of NHNE cells at
resting state (23.1  1.8 mM/pH unit at pHi 7.2) was not significantly
different from that of ATP-stimulated cells (25.8  2.7 mM/pH unit).
Therefore, the results of NKCC activity were expressed as pH unit/
min, and this value was directly analyzed without compensating for i.
Immunobolotting—NHNE cells were grown to confluence in 6-well
plates. The cells were lysed with 2 sample buffer (250 mM Tris-Cl (pH
6.5), 2% SDS, 0.1 mol/liter dithiothreitol, 0.02% bromphenol blue, 10%
glycerol). Equal amounts of whole cell lysates were resolved by 6%
SDS-PAGE and transferred to a polyvinylidene difluoride membrane
(Millipore, Bedford, MA). Membranes were blocked with 5% skim milk
in Tris-buffered saline (50 mM Tris-Cl, pH 7.5, 150 mM NaCl) for 2 h at
room temperature. This membrane was then incubated overnight with
T4 monoclonal antibody (Developmental Studies Hybridoma Bank,
Iowa City, IA) in TTBS (0.5% Tween 20 in Tris-buffered saline). After
washing with TTBS, the blot was further incubated for 45 min at room
temperature with appropriate secondary antibody (Cell Signaling) in
TTBS and then visualized using the ECL system (Amersham
Biosciences).
Statistical Analysis—The results of multiple experiments are pre-
sented as means  S.E. Statistical analysis was carried out by analysis
of variance or Student’s t test as appropriate. p  0.05 was considered
statistically significant.
RESULTS
NH4
 Transport in NHNE Cells—Na-K-2Cl cotrans-
porter activities were measured using NH4
 as a K surrogate.
As an initial step, NH4
 transport in the luminal and basolat-
eral membrane of polarized NHNE cells was measured. The
basal pHi of NHNE cells was 7.15  0.04 in Hepes-buffered
solution A, and the application of 20 mM NH4Cl to the luminal
side evoked an abrupt increase in pHi followed by a sustained
pHi increase (Fig. 1A). These results indicate that only NH3 can
pass through the luminal membrane of NHNE cells (Fig. 1C).
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At pH 7.4 and 37 °C, 20 mM NH4Cl solution contains about 0.6
mM NH3 (pKa  8.9). The charged NH4
 ion cannot pass
through the lipid bilayer of plasma membrane, whereas non-
polar NH3 can freely diffuse into the cells. When it enters the
cells, NH3 rapidly converts into NH4
 by picking up H until
equilibrium is reached. Therefore, pHi increases due to a re-
duced H concentration. However, if the cell membrane ex-
presses an NH4
-transporting protein, NH4
 enters the cells and
pHi decreases since NH4
 donates H to achieve equilibrium
with NH3 (Fig. 1C). Interestingly, applications of 20 mM NH4Cl
to the basolateral side induced a small pHi increase followed by
rapid pHi decrease, which suggests that the basolateral mem-
branes of NHNE cells have strong NH4
-transporting activities
(Fig. 1B). The average value of the initial pHi reduction caused
by basolateral challenge with 20 mM NH4Cl was 0.331  0.021
pH unit/min.
Characterization of the Basolateral NH4
-transporting Mech-
anisms—To date, several transporters are known to transport
NH4
, in particular via K binding sites (19). Therefore, we
characterized the basolateral NH4
-transporting activities of
NHNE cells. As shown in Fig. 2, we first analyzed the Na and
Cl dependence of the NH4
-transporting mechanisms. Incuba-
tion of NHNE cells in Na-free solutions for 5 min reduced the
basal pHi to 6.78  0.07. Of interest, the basolateral applica-
FIG. 1. NH4
 transport in the lumi-
nal and the basolateral membranes
of NHNE cells. pHi of NHNE cells were
measured using BCECF as described un-
der “Materials and Methods.” The mem-
brane-specific NH4
-transporting activi-
ties of polarized NHNE cells were
analyzed using a double perfusion cham-
ber with separate applications of NH4Cl
(20 mM). A, the application of NH4Cl to
the luminal side evoked an abrupt in-
crease in pHi followed by a sustained pHi
increase. LM, luminal membrane; BLM,
basolateral membrane. B, the application
of NH4Cl to the basolateral side induced a
small pHi increase followed by a rapid pHi
decrease. C, these results indicate that
only non-polar NH3 can pass through the
luminal membrane of NHNE cells. How-
ever, the basolateral membrane of NHNE
cells has strong NH4
-transporting activi-
ties (see “Results” for details).
FIG. 2. Na and Cl dependence of
the basolateral NH4
-transporting
mechanisms. The effects of Na or Cl
removal on the basolateral NH4
 trans-
port were analyzed in NHNE cells. Rep-
resentative traces of Na removal or Cl
removal are presented in A and B, respec-
tively, and a summary (each n  5) is
shown in C. Incubations in Na-free or in
Cl-free solutions abolished the basolat-
eral NH4
 transport by 96 and 83%, re-
spectively. **, p  0.01, difference from
control. LM, luminal membrane; BLM,
basolateral membrane.
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tion of NH4Cl in Na
-free solutions induced a rapid and sus-
tained pHi increase similar to that observed in the luminal
application of NH4Cl in Na
-containing solutions (Figs. 1A and
2A). Therefore, it was concluded that most of the basolateral
NH4
-transporting activities are dependent on Na, which sug-
gests that Na-independent transporters, such as KCC, do not
contribute to the NH4
-transporting activity. In addition, 83%
of the basolateral NH4
 transport was also found to be depend-
ent on Cl (Fig. 2, B and C).
Basolateral NH4
 transport was further analyzed using in-
hibitors of Na- and K-coupled transporters. As shown in Fig.
3, A and B, the Na,K ATPase inhibitor ouabain (100 M)
inhibited NH4
 transport by 28%, and the addition of the NKCC
inhibitor bumetanide (100 M) inhibited it by 94%. These re-
sults and the data concerning Na and Cl dependence indi-
cate that NKCC mediates most of the basolateral NH4
 trans-
port in NHNE cells, particularly when treated with ouabain.
Subsequently, the expression of NKCC1 in NHNE cells was
verified by immunoblotting. Protein extracts of NHNE cells
originating from two different individuals showed a band at
around 170 kDa when blotted with T4 anti-NKCC1 monoclonal
antibody, which corresponds to the size of typical glycosylated
human NKCC1 (Fig. 3C). In addition, reverse transcriptase-
PCR experiments using specific primers of human NKCC1 and
NKCC2 revealed that NHNE cells contain only NKCC1 mRNA
(not shown).
Activation of NKCC1 by Purinergic Stimulation—Accumu-
lating evidence suggests that P2 receptors participate in the
regulation of transepithelial ion transport in various epithelia
(3). To investigate the effects of P2R on NKCC, we first meas-
ured [Ca2]i in response to the membrane-specific applications
of P2R agonists. As shown in Fig. 4A, both luminal and baso-
lateral applications of ATP evoked [Ca2]i signals in NHNE
cells. Interestingly, P2Rs in the luminal membrane (ED50 for
ATP, 4.3 M) showed 	5 times higher agonist sensitivity than
those of the basolateral membrane (ED50 for ATP, 23.7 M). We
next evaluated the effects of P2R stimulation on basolateral
NKCC activity using the protocols described above. A summary
of the results is presented in Fig. 4B, and representative traces
of basolateral ATP and luminal ATP stimulations are shown in
Fig. 4, C and D, respectively. Importantly, the stimulation of
P2Rs either in the basolateral membrane or in the luminal
membrane increased the NKCC activity in NHNE cells. Con-
trol basolateral NH4
-transporting activity under ouabain
treatment was 0.223 0.017 pH unit/min, and this value was
increased to 0.496  0.075 and 0.569  0.102 by basolateral
and luminal ATP applications, respectively.
Effects of Ion Channel Blockers and PKC Inhibitors—Al-
though we observed that stimulation of either luminal or ba-
solateral P2R activated NKCC, we first analyzed the stimula-
tory mechanisms of basolateral P2R, which resides in the same
membrane as NKCC. Previous studies have reported that var-
ious agonists can secondarily regulate NKCC activity by pri-
marily modulating intracellular ionic compositions (5). In par-
ticular, lowering [Cl]i by the activation of luminal Cl

channels and the counter activation of basolateral K channels
has been suggested to be an important regulatory mechanism
of NKCC (5, 20, 21). Therefore, we tested whether the stimu-
latory effects of basolateral P2R can be inhibited by blockers of
Cl or K channels. To block luminal Cl channels, a mixture
of the Ca2-activated Cl channel (CACC) inhibitor DIDS (100
M) and of the CFTR inhibitor NPPB (30 M) was applied to the
luminal perfusates (Fig. 5C). As for the basolateral K chan-
nels, a non-specific K channel inhibitor Ba2 (5 mM) was
FIG. 3. Functional and molecular
expression of NKCC1 in NHNE cells.
Basolateral NH4
 transport was measured
with solutions containing the Na,K
ATPase inhibitor ouabain and the NKCC
inhibitor bumetanide. A, a representative
trace showing the effects of ouabain (100
M) and bumetanide (100 M). LM, lumi-
nal membrane; BLM, basolateral mem-
brane. B, summarized results of six ex-
periments. C, immunoblotting of protein
extracts of NHNE cells originating from
two separate individuals using T4 anti-
NKCC1 monoclonal antibody. *, p  0.05,
**, p  0.01, difference from control.
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included in the basolateral perfusates (Fig. 5D). As shown in
Fig. 5B, neither blockade of the Cl channel nor of the K
channel affected the stimulatory effects of ATP on NKCC. In
addition, the blockade of ENaC, which may affect NKCC activ-
ity by modulating the membrane potential or [Na]i by adding
100 M amiloride to the luminal perfusates, did not alter NKCC
activity (not shown). Therefore, it was concluded that the in-
creased NKCC activity in response to stimulation of basolat-
eral P2R was due to the intrinsic activation of NKCC.
Recently, it was suggested that the -adrenergic agonist
methoxamine stimulates NKCC by activating protein kinase C
(PKC), in particular, by activating a novel type PKC- isoform
FIG. 4. Activation of NKCC by P2R stimulation. A, [Ca2]i was measured in NHNE cells with basolateral and luminal applications of ATP.
LM, luminal membrane; BLM, basolateral membrane. B, summarized results of NKCC measurements with basolateral (n  5) or luminal ATP
stimulation (n  5). C, effects of basolateral P2R stimulation on NKCC were determined by comparing the pH decreases (pH unit/min) due to
intracellular NH4
 uptake in control and ATP-stimulated (BLM) conditions. To prevent Na,K ATPase-mediated NH4
 uptake, ouabain (100 M)
was added to the basolateral solutions. D, effects of luminal P2R stimulation on NKCC were measured using the same protocols as described in
panel C, except that ATP was applied to the luminal side. *, p  0.05, difference from control.
FIG. 5. Effects of Cl and K channel blockers on NKCC activation by basolateral ATP. A, a diagram of the possible secondary activation
of NKCC by the activation of luminal Cl channels and the counter activation of basolateral K channels (see “Results” for details). B, summarized
results of NKCC measurements with the blockers of Cl channels (n  5) and those of K channels (n  4). LM, luminal membrane; BLM,
basolateral membrane. C, the effects of Cl channel blockers were analyzed in basolaterally ATP-stimulated cells. To block luminal Cl channels,
a mixture of CACC inhibitor DIDS (100 M) and CFTR inhibitor NPPB (30 M) was applied to the luminal perfusates. D, effects of K channel
blockers. To block the basolateral K channels, a non-specific K channel inhibitor, Ba2 (5 mM), was added to basolateral perfusates.
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in Calu-3 cells originating from human lung adenocarcinoma
(22). The stimulation of P2R, especially the stimulation of
G-protein-coupled P2Y receptors, can activate PKC. Therefore,
we tested whether the stimulatory effects of P2R on NKCC are
dependent on PKC activity in NHNE cells using two types of
PKC inhibitors. Cells were pretreated for 30 min with either
Go6976 (500 nM), an inhibitor of classic PKC isoforms, or rot-
tlerin (10 M), an inhibitor of novel PKC isoforms. NKCC
activity was then measured using the luminal and basolateral
perfusates containing the same inhibitor concentrations. Un-
like the findings observed in Calu-3 cells after methoxamine
stimulation (22), the effects of P2R stimulation in NHNE cells
FIG. 6. Role of [Ca2]i in NKCC activation by basolateral ATP. A, NKCC-mediated NH4
 transport was measured with ionomycin treatment
(5 M). BLM, basolateral membrane. B, NKCC activities were measured in BAPTA-AM-pretreated (50 M, 30 min) cells. C, summarized results
of ionomycin (n  5) and BAPTA (n  7) treatment. Basolateral ATP-stimulated NKCC activity without BAPTA treatment was adopted from Fig.
4B. *, p  0.05, **, p  0.01, difference from control.
FIG. 7. Effects of long term ATP stimulation on NKCC activity. A, [Ca2]i was measured with basolateral ATP for 4 min in NHNE cells.
BLM, basolateral membrane. B, basolateral ATP was applied 3 min before the NKCC measurement. C, a summary of the results (n  5). NKCC
activity with simultaneous basolateral ATP treatment was adopted from Fig. 4B. **, p  0.01, difference from control.
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were not inhibited either by Go6976 or by rottlerin. Basolateral
ATP-stimulated NKCC activity after Go6976 treatment was
0.462  0.059 pH unit/min (n  5), and after rottlerin treat-
ment, it was 0.443  0.055 (n  5). These values were not
significantly different from the value of basolateral ATP stim-
ulation presented in Fig. 4B (0.496  0.075, see above).
The Effects of Basolateral P2R Are Dependent on [Ca2]i—As
shown in Fig. 4A, either luminal or basolateral ATP evoked a
rapid increase in [Ca2]i. Therefore, we investigated the role of
calcium signals in NKCC activation. First, we measured the
effects of [Ca2]i increase on NKCC activity using the Ca
2
ionophore ionomycin. As shown in Fig. 6, A and C, ionomycin
treatment (5 M) acutely increased the basolateral NKCC ac-
tivity by 98%. Next, we investigated whether the calcium sig-
nals are required for the P2R-induced activation of NKCC.
Surprisingly, the chelation of intracellular Ca2 by BAPTA-AM
treatment (50 M for 30 min) almost completely blocked the
activation of NKCC by basolateral P2R stimulation (Fig. 6, B
and C).
As depicted in Fig. 7A, stimulation of P2R caused a short-
lived [Ca2]i peak followed by a small sustained [Ca
2]i in-
crease in NHNE cells. Of interest, treatment with basolateral
ATP 3 min before the application of NH4Cl did not increase
NKCC activity (Fig. 7, B and C). These results suggest that the
P2R-induced stimulation of NKCC activity is highly correlated
with [Ca2]i.
Characterization of the Effects of Luminal P2R on NKCC—
The stimulatory effects of luminal P2R on NKCC were ana-
lyzed using protocols similar to those used for the investigation
of basolateral P2R. As was observed with basolateral ATP,
inhibition of ENaC and PKC did not significantly alter the
effects of luminal ATP on NKCC (not shown). However, unlike
that observed with basolateral ATP, the blockade of luminal
Cl channels partially reduced the stimulatory effects of lumi-
nal ATP on NKCC (Fig. 8, A and B). The luminal ATP-stimu-
lated NKCC activity was 0.532  0.040 pH unit/min, and this
value was decreased to 0.401  0.029 by luminal DIDS and
NPPB. Finally, the effects of luminal ATP were measured in
the BAPTA-pretreated cells. As illustrated in Fig. 8, C and D,
the stimulatory effects of luminal ATP on NKCC were com-
pletely blocked by the chelation of intracellular calcium, as was
observed in experiments with basolateral ATP.
DISCUSSION
Secretion of appropriate fluids is critical in the mucociliary
clearance system, which protects the respiratory system from
noxious substances. An interesting feature is that airway sur-
face epithelium is capable of releasing ATP and UTP to the
luminal space in response to a myriad of physiologic and patho-
logic stimuli. Moreover, neuroendocrine cells and mast cells
along the airway also release ATP to the interstitial space,
hence to the basolateral side of surface epithelium, with other
agonists from their granules (3, 23). Therefore, purinergic sig-
naling is thought to serve as an important regulatory mecha-
nism of epithelial homeostasis and to be involved in a number
of pathologic conditions.
The present study provides sufficient and necessary evidence
that purinergic agonists directly activate basolateral NKCC via
calcium signaling in human nasal epithelia. Increased [Ca2]i
by ionomycin treatment sufficiently activated the basolateral
NKCC in NHNE cells (Fig. 6A). In addition, the finding that
[Ca2]i chelation by BAPTA treatment completely inhibited the
FIG. 8. Inhibition of luminal ATP-induced NKCC activation by Cl channel blockade and by [Ca2]i chelation. A, effects of Cl

channel blockers were analyzed in NHNE cells using the protocols described in the legend for Fig. 5 (panel B), except that the cells were stimulated
with luminal ATP. LM, luminal membrane; BLM, basolateral membrane. B, a summary of Cl channel block on luminal ATP (n 5). C, the effects
of [Ca2]i chelator BAPTA were analyzed in NHNE cells using the protocols described in the legend for Fig. 6 (panel B), except that the cells were
stimulated with luminal ATP. D, a summary of [Ca2]i chelation on luminal ATP (n 5). Luminal ATP-stimulated NKCC activity without BAPTA
treatment was adopted from Fig. 4B. *, p  0.05, **, p  0.01, difference from control.
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P2R-induced effects (Figs. 6B and 8C) demonstrated that cal-
cium signals are required for the P2R-induced activation of
NKCC. Previously, it has been shown that an increase in
[Ca2]i can modulate NKCC activity in several tissues includ-
ing airway epithelia (5). However, most of the studies have
suggested that calcium signals do not directly modulate NKCC
but rather affect NKCC activity by secondarily modulating K
or Cl conductances (5, 20, 21). On the other hand, the present
findings that inhibitors of Cl or K channels did not affect the
stimulatory effects of basolateral ATP on NKCC (Fig. 5) and
only partially inhibited those of luminal ATP (Fig. 8) strongly
suggest that purinergic stimulation induced an intrinsic in-
crease in NKCC activity.
One of the basic differences between the present study and
previous studies is the method used for determining NKCC
activity. We employed a technique that has a high temporal
resolution by measuring the real-time changes in pHi due to
NKCC-mediated intracellular NH4
 uptake. Previous studies
that have reported only the secondary effects of [Ca2]i used
either [3H]bumetanide binding or 86Rb fluxes to determine
NKCC activity and measured averaged NKCC activities after
long term incubations with agonists (20, 21). For example,
Haas et al. (20) reported that treatment with luminal ATP for
40 min increased [3H]bumetanide binding by about 80% in
canine tracheal epithelia and this increase was almost com-
pletely blocked by the Cl channel blocker IAA-94. As shown in
the present study, P2R stimulation evoked a short-lasting Ca2
peak even in the continuous presence of ATP (Fig. 7). In native
tissues, released ATP and UTP are rapidly washed away by the
bulk of luminal or interstitial fluids and are instantaneously
degraded by ecto-enzymes (3, 23). Therefore, repetitive short-
lasting P2R stimuli rather than a continuous stimulation
would be closer to actual physiological situations. In this re-
gard, our present finding that a short-lasting Ca2 peak in-
duced by P2R acutely increases the intrinsic activity of NKCC
may have important physiological implications.
A previous study on cholinergic regulation of NKCC in parotid
acinar cells reported results that concur with ours (Evans and
Turner (17)). These authors also determined NKCC activity by
measuring pHi decreases due to NKCC-mediated NH4
 uptake
and found the acute up-regulation of intrinsic NKCC activity by
the cholinergic agonist carbachol, which was completely inhibited
by BAPTA but not by intracellular KCl loss or cell shrinkage.
Recently, Brindikova et al. (24) reported that long term (30 min)
purinergic stimulation inhibits NKCC-mediated 86Rb fluxes in
C11-MDCK cells but not in C7-MDCK cells. However, short term
(2 min) purinergic stimulation acutely increased the NKCC ac-
tivities in both MDCK cell lines, and this was completely inhib-
ited by BAPTA treatment (24). Together with the present find-
ings, the above results suggest that the acute activation of NKCC
by transient increases in [Ca2]i does not seem to be a phenom-
enon specific to NHNE cells and that it may be a ubiquitous
feature in epithelial tissues.
It is widely accepted that phosphorylation of NKCC1 is re-
lated to the increased activity of NKCC1 (25, 26). Activities of
various kinases such as PKA, PKC, and of an unidentified
kinase responding to [Cl]i were suggested to be associated
with NKCC1 phosphorylation and activation (5, 26). In fact, it
was once reported that the activity of a novel PKC- isoform
was required for the methoxamine-induced activation of
NKCC1 in Calu-3 cells (22). However, the present results ob-
tained using PKC inhibitors suggested that the classical and
novel isoforms of PKC are not involved in the P2R-induced
acute activation of NKCC in NHNE cells. The molecular mech-
anisms underlying P2R- and Ca2-induced activation of
NKCC1 require further study.
Previously, we showed that P2R signals evoke the mem-
brane-specific activation of ion transporters in polarized epi-
thelial tissues (27, 28). In the present study, the stimulatory
effects of luminal ATP on NKCC were partially inhibited by the
blockade of luminal Cl channels (Fig. 8), whereas the stimu-
latory effects of basolateral ATP were not (Fig. 5). Since the
effects of luminal ATP were completely inhibited by chelation
of intracellular Ca2, Cl channels responding to [Ca2]i such
as CACC are responsible, at least in part, for the luminal
ATP-induced activation of NKCC. The finding that luminal Cl
channels are activated only by luminal ATP but not by baso-
lateral ATP supports the idea of compartmentalized calcium
signals in epithelial cells, as suggested by ourselves and by
other researchers (11, 27–29).
In conclusion, we observed that P2R stimulation acutely
activated NKCC in NHNE cells. The apical surfaces of the
airway tract are moistened by ASF that derives from the tran-
scellular transport of anions, especially Cl ions. Since the activ-
ity of basolateral NKCC, which maintains [Cl]i at the levels
above the predicted equilibrium potential, is actually the rate-
limiting step in epithelial fluid secretion, the results described
here add significantly to our understanding of airway secre-
tions in physiologic and pathologic conditions. For example,
NKCC activation due to ATP release by activated mast cells
may contribute to increased nasal secretions in allergic
rhinitis.
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